Guru Program Pioneered by Tom Gable Receives Official Registration from USPTO
The United States Patent and Trademark Office (USPTO) has registered Guru Program® as a service mark for a public relations strategy developed and honed by Tom Gable, of Gable PR, over more than two decades. The official USPTO
language said the mark covered: consulting services related to pub...
Acclarent, Inc. Granted Key Patent Covering Balloon Sinuplasty(TM) Technologies
...cts an important portion of Acclarent's technology assets and further differentiates Acclarent as a leader in the ENT community. The validation by the uspto
of our invention is a significant step in continuing to provide physicians and patients with access to safe and effective minimally invasive technolog...
United States Patent & Trademark Office (USPTO) Rules in Smith & Nephew's Favor and Confirms Patent Claims Infringed by Arthrex Inc.
...against it, Arthrex initiated a standard re-examination proceeding with the uspto
to try to declare the patent invalid. The uspto
ruling confirms the validity of the claims of the patent that are infringed...
USPTO Confirms Validity of Bystolic(R) Patent
...s of the reexamination proceedings for the patent for Bystolic(R) and confirmed the validity of all of the previously granted claims. As a result, the uspto
has issued a Notice of Intent to Issue Ex Parte Reexamination Certificate for U.S. Patent No. 6,545,040 (the '040 patent) to Janssen Pharmaceutica N.V...
Winners Announced in 2008 Collegiate Inventors Competition(R)
...nventors Hall of Fame and
representatives from the uspto
The prominent group of judges ...
For over 200 years, the basic role of the uspto
has remained the same: to
promote the progress of ...inating both patent and trademark
information, the uspto
promotes an understanding of intellectual property...
Cardo Medical Announces FDA Clearance of the Align 360 Total Knee System
...throplasty and replacement, many of which have already
received FDA clearance. Cardo Medical has a robust and innovative product
pipeline pending both uspto
and FDA submission and clearance.
Cardo Medical works in small, focused development teams in concert with
physicians to rapidly develop products fro...
Public Interest Groups Back Federal Court Appeal to Implement New U.S. Patent Rules; Proposed Regulations Would Curtail Abusive Behavior by Patent Applicants
...wo continuations per application and to assist the uspto
performing initial technological research on ap...ons," the brief said. "First, they will
enable the uspto
to curtail abuses of the patent application proces...r
advantage. Second, the Final Rules will help the uspto
quality, which is a critical issue ...
CryoCath Provides Update on Patent Infringement Lawsuit
...ion or the foreign counterparts.
Last month, the uspto
declared an Interference to determine the first
to...ing technology. By declaring the Interference,
allows CryoCath to get involved and present eviden...nstrate CryoCath's priority to the technology. The uspto
a system of "first-to-invent" rathe...
GenOdyssee Receives Notice of Allowance from U.S. Patent Office for Improved Interferon-Alpha Aimed at Hepatitis C
...ce of allowance report on this product that was
issued in 2006, the current uspto
notice of allowance report did not reveal
any prior art references relevant...to the invention constituted by GEA007.1.
A recent communication with the uspto
revealed that GenOdyssee's patent
application covering a second lead IFN-al...
Collegiate Inventors Competition announces winners for 2007
...ctees from the National Inventors Hall of Fame and representatives from the uspto
Jeffrey Dollinger, President of Invent Now, Inc., the subs...l guest judges were Jasemine Chambers, Biotechnology Group Director for the uspto
and Jeffrey Pan, Advanced Technology, Global Pharmaceutical Discovery for A...
USPTO in Medical Technology
Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
...g many of these CNS disorders.
Christopher M. Starr, Ph.D., Raptor's Chief Executive Officer and Co-Founder, commented, "We are pleased that the uspto
has allowed pivotal claims that may offer strong IP protection to our NeuroTrans(TM) program. The broad claims are designed to protect the use of our ...
Pharmasset Receives Notice of Allowance
...t has nominated as a
lead development candidate.
"We are pleased that the uspto
has recognized our intellectual property
rights in our growing pipeline of ...lve risks and uncertainties, including without limitation the risk
that the uspto
will withdraw the Notice of Allowance, adverse events could
cause the cessa...
USPTO in Biological News
USPTO in Biological Technology
Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
HAMILTON, Bermuda, Sept. 17 /PRNewswire-FirstCall/ -- Warner Chilcott
Limited (Nasdaq: WCRX ) announced today that LEO Pharma A/S ("LEO") has
received a non-final Action Closing Prosecution from the U.S. Patent and
Trademark Office (the "USPTO"). In September 2006, the USPTO
Sensenbrenner and USPTO Director highlight benefits of technology transfer
Hartland, Wis. At a meeting Monday highlighting university-business partnerships in Wisconsin, Camtronics Medical Systems, Ltd. , a medical imaging company based in Hartland, Wis., demonstrated its latest tool for assessing cardiovascular health to John Dudas, acting under secretary of commerce f...
US Patent Office Rejects 95% of Verathon Claims in Patent Case With Aircraft Medical
...e-examination of this patent in 2006 following litigation (currently on
hold) that Verathon initiated against Aircraft.
The new Action from the uspto
has rejected 393 claims that Verathon
introduced during the re-examination procedure on grounds that they had
impermissibly enlarged the scope of the ...
Rising H9N2 Influenza Replikin Count Has Doubled That of H5N1
...etic Taura Syndrome virus oral vaccine 91% protective in shrimp (see refs.).
References and Notes:
Detailed replikins data are published at the uspto
Replikins, Ltd. now is publishing two monthly e-mail reports by subscription:
1) "FluForecast®" - monthly r...
Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
...exone, the two active agents in Contrave. It is a companion
to the Weber/Cowley composition patent (U.S. Patent No. 7,375,111) which was
issued by the uspto
in May 2008 and broadly covers sustained release (SR)
compositions of bupropion and naltrexone combined in a single dosage form. The
Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results
...on patent (U.S. 7,375,111) which was issued by the uspto
2008, which covers SR compositions of bupro... in the
second half of 2009.
-- In addition, the uspto
issued U.S. Patent No. 7,425,571 providing
broad c...ugs for the treatment of obesity through 2023. The uspto
issued U.S. Patent No. 7,429,580 which br...
Prometheus Strengthens Intellectual Property Portfolio with Newly Issued Patents for Thiopurine Metabolite Testing
thiopurines to reach and maintain desired therapeutic levels. The uspto
approved the issuance of the claims in U.S. Patent Nos. 7,425,546 and
7...of immune- mediated gastrointestinal disorders."
"We are pleased that the uspto
has acknowledged the validity of these
patents and approved their issuance,...
Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain
...5,571 providing broad
coverage of the use of zonisamide either alone or in combination with other
drugs for the treatment of obesity through 2023. The uspto
has also issued
U.S. Patent No. 7,429,580 which broadly covers zonisamide in combination
with various marketed atypical antipsychotics including olanz...
HemoGenix(R), Inc. Receives Issued Patent for its HALO(R) Technology Platform From the United States Patent and Trademark Office (USPTO).
...ely-held contract research and assay development company,
reported that the uspto
has issued the first two of several patent
applications for the company's H...Hemotoxicity
Instrumental in the issuance of the patents by the uspto
Rosenbaum and Donna Becker of Rosenbaum & Associates, P.C. of No...
OPKO Health Announces Issuance of U.S. Patent Covering the Use and Administration of Certain Anti-VEGF siRNA's, Including Its Phase III Compound Bevasiranib
...nistration. This newly issued patent broadly
protecting the applications of OPKO's siRNA bevasiranib is the second for
the compound. In late 2006, the uspto
issued a patent covering
bevasiranib's composition of matter.
"This patent marks another important step in establishing OPKO's
leadership position i...
USPTO in Biological Definition
Jones, Orlando, " US2000 Improvement in the manufacture of starch ". (Class: 127/68; 48/119; 127/69). Middlesex, England, uspto